World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 68 2125 1940 890 786 228 26293

Roy M. Gulick publications per year

The chart shows the history of publications by Roy M. Gulick between 1980 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Roy M. Gulick published across 46 years, from 1980 to 2025, averaging 5.7 papers a year. Output peaked at 18 publications in 2021. 9 of the 262 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1980 to 2025. Vertical axis: number of publications, 0 to 18. Peak 18 publications in 2021. 1980: 1 publication 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 1 publication 1990: 3 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 1 publication 1995: 0 publications 1996: 1 publication 1997: 7 publications 1998: 6 publications 1999: 2 publications 2000: 8 publications 2001: 8 publications 2002: 7 publications 2003: 3 publications 2004: 13 publications 2005: 13 publications 2006: 9 publications 2007: 13 publications 2008: 15 publications 2009: 9 publications 2010: 14 publications 2011: 7 publications 2012: 15 publications 2013: 5 publications 2014: 11 publications 2015: 7 publications 2016: 10 publications 2017: 6 publications 2018: 12 publications 2019: 7 publications 2020: 10 publications 2021: 18 publications 2022: 3 publications 2023: 8 publications 2024: 6 publications 2025: 3 publications
1980 2025

262 publications in total across all disciplines

View publications per year as a table
Roy M. Gulick: publications per year, 1980 to 2025
Year Publications
1980 1
1981 0
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 1
1990 3
1991 0
1992 0
1993 0
1994 1
1995 0
1996 1
1997 7
1998 6
1999 2
2000 8
2001 8
2002 7
2003 3
2004 13
2005 13
2006 9
2007 13
2008 15
2009 9
2010 14
2011 7
2012 15
2013 5
2014 11
2015 7
2016 10
2017 6
2018 12
2019 7
2020 10
2021 18
2022 3
2023 8
2024 6
2025 3
Total 262
Download as CSV

Roy M. Gulick publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roy M. Gulick sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 225–234 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 228 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155 228
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Roy M. Gulick D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roy M. Gulick sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 68 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 68 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103 68
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Roy M. Gulick is a researcher affiliated with Cornell University in the United States with a focus on medicine, particularly within infectious diseases. Their work spans multiple subfields, including infectious diseases, virology, epidemiology, neurology, and emergency medicine.

The main topics of Roy M. Gulick's research encompass:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • HIV-related health complications and treatments
  • COVID-19 and healthcare impacts

Roy M. Gulick has contributed to numerous publications, with frequent appearances in the following venues:

  • UNC Libraries
  • Annals of Internal Medicine
  • Clinical Infectious Diseases
  • New England Journal of Medicine
  • AIDS and Behavior

Recent representative papers include:

  • "Clinical Characteristics of Covid-19 in New York City" (2020), New England Journal of Medicine
  • "Severe Covid-19" (2020), New England Journal of Medicine
  • "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women" (2021), New England Journal of Medicine
  • "COVID-19 in Hospitalized Adults With HIV" (2020), Open Forum Infectious Diseases
  • "Obesity and COVID-19 in New York City: A Retrospective Cohort Study" (2020), Annals of Internal Medicine

Collaborations form an important part of Roy M. Gulick's work, with frequent coauthors including:

  • Raphael J. Landovitz
  • Kenneth H. Mayer
  • Eric S. Daar
  • Marybeth McCauley
  • Mark A. Marzinke

Recognized by peers, Roy M. Gulick is a member of the Association of American Physicians, reflecting a standing within the medical community.

Best Publications

  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

    R M Gulick;J W Mellors;D Havlir;J J Eron

  • Clinical Characteristics of Covid-19 in New York City.

    Parag Goyal;Justin J. Choi;Laura C. Pinheiro;Edward J. Schenck

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Severe Covid-19

    David A. Berlin;Roy M. Gulick;Fernando J. Martinez

  • Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

    Roy M. Gulick;Jacob Lalezari;James Goodrich;Nathan Clumeck

  • Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

    Marina Caskey;Florian Klein;Julio C. C. Lorenzi;Michael S. Seaman

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti

    Patrice Severe;Marc Antoine Jean Juste;Alex Ambroise;Ludger Eliacin

  • Combination therapy with anti-HIV-1 antibodies maintains viral suppression

    Pilar Mendoza;Henning Gruell;Lilian Nogueira;Joy A. Pai

  • HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

    Johannes F. Scheid;Johannes F. Scheid;Joshua A. Horwitz;Yotam Bar-On;Edward F. Kreider

  • Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

    Marina Caskey;Till Schoofs;Henning Gruell;Allison Settler

  • Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti

    Patrice Severe;Paul Leger;Macarthur Charles;Francine Noel

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals

    David B. Clifford;Scott Evans;Yijun Yang;Edward P. Acosta

  • Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.

    Roy M. Gulick;Zhaohui Su;Charles Flexner;Michael D. Hughes

  • ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

    Robert L. Murphy;Scott Brun;Charles Hicks;Joseph J. Eron

  • Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection: 100-Week Follow-up

    Roy M. Gulick;John W. Mellors;Diane Havlir;Joseph J. Eron

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • 3-Year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

    Roy M. Gulick;John W. Mellors;Diane Havlir;Joseph J. Eron

Frequent Co-Authors

Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
David W. Haas
David W. Haas Vanderbilt University Medical Center
Richard Haubrich
Richard Haubrich University of California, San Diego
Charles Flexner
Charles Flexner Johns Hopkins University
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Robert L. Murphy
Robert L. Murphy Northwestern University
Susan A. Fiscus
Susan A. Fiscus University of North Carolina at Chapel Hill
Eric S. Daar
Eric S. Daar Lundquist Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open diverse career paths, especially for students seeking flexible learning options. For those interested in public health, considering mph online programs with easy admission requirements is a smart way to advance without the stress of strict entry criteria.

Many graduates also explore allied health fields. For example, becoming a child.life specialist salary can be rewarding, combining science knowledge with emotional support skills.

Importantly, online education provides accessible opportunities for diverse populations, including those with past convictions. Programs highlighted under college degrees for felons demonstrate how higher education can be inclusive and supportive, allowing individuals to rebuild their careers.

For those interested in nursing and holistic health, functional medicine np programs offer specialized tracks that blend traditional microbiology with innovative patient care approaches.

Altogether, these pathways illustrate the versatility of microbiology foundations and the wide range of accessible online degrees that can lead to meaningful, well-paying careers.

Best Scientists Citing Roy M. Gulick

Trending Scientists

Recently Published Articles